The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...

The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment ...

Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa ...

Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients ...

Cutting staff is quick way to lower your costs, but a haphazard approach like DOGE's could cost your company if you ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

The FDA doesn’t plan to execute a reorganization of the agency but will consolidate offices that handle travel, technology, ...

The rolls were sold at the retail level in Pennsylvania, California, Connecticut, Maryland, Delaware, and Ohio, according to ...

The FDA has paused a quality control program for milk and dairy products. Food safety experts are concerned, but they say our ...